Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNAMO 2: Mericitabine + Boceprevir in HCV
NCT01482403Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of mericitabine in hepatitis C (HCV), sponsored by Roche. Started Nov 2011; status: completed.
02
Drugs
mericitabine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01482403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01482403.